Amyloid-β peptide activates cultured astrocytes: Morphological alterations, cytokine induction and nitric oxide release

Jingru Hu, Keith T. Akama, Grant A. Krafft, Brett A. Chromy, Linda J. Van Eldik

Research output: Contribution to journalArticle

239 Citations (Scopus)

Abstract

A common feature of many neurodegenerative disorders is an abundance of activated glial cells (astrocytes and microglia). In Alzheimer's disease (AD), activated astrocytes are in close apposition to and surrounding the amyloid plaques. The mechanisms by which the astrocytes become activated in AD and the consequences of reactive astrocytosis to disease progression are not known. We examined the possibility that the amyloid-β (A β) peptide, a major constituent of the amyloid plaque, could act as a stimulus leading to activation. We found that treatment of rat cortical astrocyte cultures with aggregated A β 1-42 peptide induces activation, as assessed by reactive morphological changes and upregulation of selective glial mRNA and proteins, such as the inflammatory cytokine interleukin-1 β. A β also stimulates inducible nitric oxide synthase (iNOS) mRNA levels and nitric oxide (NO) release. A β 1-42, a major form of amyloid associated with neurotoxicity, activated astrocytes in a time- and dose-dependent manner, whereas a scrambled A β 1-42 sequence or A β 17-42 had little or no effect. We also determined that the A β activity can be found in a supernatant fraction containing soluble A β oligomers. Our data suggest that A β plays a role in the reactive astrocytosis of AD and that the inflammatory response induced upon glial activation is a critical component of the neurodegenerative process.

Original languageEnglish (US)
Pages (from-to)195-206
Number of pages12
JournalBrain Research
Volume785
Issue number2
DOIs
StatePublished - Mar 2 1998
Externally publishedYes

Fingerprint

Amyloid
Astrocytes
Nitric Oxide
Cytokines
Peptides
Neuroglia
Alzheimer Disease
Gliosis
Amyloid Plaques
A 17
Messenger RNA
Microglia
Nitric Oxide Synthase Type II
Interleukin-1
Neurodegenerative Diseases
Disease Progression
Up-Regulation
Proteins

Keywords

  • Alzheimer's disease
  • Astrocyte
  • Beta amyloid
  • Interleukin-1
  • Nitric oxide synthase

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Amyloid-β peptide activates cultured astrocytes : Morphological alterations, cytokine induction and nitric oxide release. / Hu, Jingru; Akama, Keith T.; Krafft, Grant A.; Chromy, Brett A.; Van Eldik, Linda J.

In: Brain Research, Vol. 785, No. 2, 02.03.1998, p. 195-206.

Research output: Contribution to journalArticle

Hu, Jingru ; Akama, Keith T. ; Krafft, Grant A. ; Chromy, Brett A. ; Van Eldik, Linda J. / Amyloid-β peptide activates cultured astrocytes : Morphological alterations, cytokine induction and nitric oxide release. In: Brain Research. 1998 ; Vol. 785, No. 2. pp. 195-206.
@article{01c1d6d5c5fe41679832a4cb66eebf71,
title = "Amyloid-β peptide activates cultured astrocytes: Morphological alterations, cytokine induction and nitric oxide release",
abstract = "A common feature of many neurodegenerative disorders is an abundance of activated glial cells (astrocytes and microglia). In Alzheimer's disease (AD), activated astrocytes are in close apposition to and surrounding the amyloid plaques. The mechanisms by which the astrocytes become activated in AD and the consequences of reactive astrocytosis to disease progression are not known. We examined the possibility that the amyloid-β (A β) peptide, a major constituent of the amyloid plaque, could act as a stimulus leading to activation. We found that treatment of rat cortical astrocyte cultures with aggregated A β 1-42 peptide induces activation, as assessed by reactive morphological changes and upregulation of selective glial mRNA and proteins, such as the inflammatory cytokine interleukin-1 β. A β also stimulates inducible nitric oxide synthase (iNOS) mRNA levels and nitric oxide (NO) release. A β 1-42, a major form of amyloid associated with neurotoxicity, activated astrocytes in a time- and dose-dependent manner, whereas a scrambled A β 1-42 sequence or A β 17-42 had little or no effect. We also determined that the A β activity can be found in a supernatant fraction containing soluble A β oligomers. Our data suggest that A β plays a role in the reactive astrocytosis of AD and that the inflammatory response induced upon glial activation is a critical component of the neurodegenerative process.",
keywords = "Alzheimer's disease, Astrocyte, Beta amyloid, Interleukin-1, Nitric oxide synthase",
author = "Jingru Hu and Akama, {Keith T.} and Krafft, {Grant A.} and Chromy, {Brett A.} and {Van Eldik}, {Linda J.}",
year = "1998",
month = "3",
day = "2",
doi = "10.1016/S0006-8993(97)01318-8",
language = "English (US)",
volume = "785",
pages = "195--206",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Amyloid-β peptide activates cultured astrocytes

T2 - Morphological alterations, cytokine induction and nitric oxide release

AU - Hu, Jingru

AU - Akama, Keith T.

AU - Krafft, Grant A.

AU - Chromy, Brett A.

AU - Van Eldik, Linda J.

PY - 1998/3/2

Y1 - 1998/3/2

N2 - A common feature of many neurodegenerative disorders is an abundance of activated glial cells (astrocytes and microglia). In Alzheimer's disease (AD), activated astrocytes are in close apposition to and surrounding the amyloid plaques. The mechanisms by which the astrocytes become activated in AD and the consequences of reactive astrocytosis to disease progression are not known. We examined the possibility that the amyloid-β (A β) peptide, a major constituent of the amyloid plaque, could act as a stimulus leading to activation. We found that treatment of rat cortical astrocyte cultures with aggregated A β 1-42 peptide induces activation, as assessed by reactive morphological changes and upregulation of selective glial mRNA and proteins, such as the inflammatory cytokine interleukin-1 β. A β also stimulates inducible nitric oxide synthase (iNOS) mRNA levels and nitric oxide (NO) release. A β 1-42, a major form of amyloid associated with neurotoxicity, activated astrocytes in a time- and dose-dependent manner, whereas a scrambled A β 1-42 sequence or A β 17-42 had little or no effect. We also determined that the A β activity can be found in a supernatant fraction containing soluble A β oligomers. Our data suggest that A β plays a role in the reactive astrocytosis of AD and that the inflammatory response induced upon glial activation is a critical component of the neurodegenerative process.

AB - A common feature of many neurodegenerative disorders is an abundance of activated glial cells (astrocytes and microglia). In Alzheimer's disease (AD), activated astrocytes are in close apposition to and surrounding the amyloid plaques. The mechanisms by which the astrocytes become activated in AD and the consequences of reactive astrocytosis to disease progression are not known. We examined the possibility that the amyloid-β (A β) peptide, a major constituent of the amyloid plaque, could act as a stimulus leading to activation. We found that treatment of rat cortical astrocyte cultures with aggregated A β 1-42 peptide induces activation, as assessed by reactive morphological changes and upregulation of selective glial mRNA and proteins, such as the inflammatory cytokine interleukin-1 β. A β also stimulates inducible nitric oxide synthase (iNOS) mRNA levels and nitric oxide (NO) release. A β 1-42, a major form of amyloid associated with neurotoxicity, activated astrocytes in a time- and dose-dependent manner, whereas a scrambled A β 1-42 sequence or A β 17-42 had little or no effect. We also determined that the A β activity can be found in a supernatant fraction containing soluble A β oligomers. Our data suggest that A β plays a role in the reactive astrocytosis of AD and that the inflammatory response induced upon glial activation is a critical component of the neurodegenerative process.

KW - Alzheimer's disease

KW - Astrocyte

KW - Beta amyloid

KW - Interleukin-1

KW - Nitric oxide synthase

UR - http://www.scopus.com/inward/record.url?scp=0032473596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032473596&partnerID=8YFLogxK

U2 - 10.1016/S0006-8993(97)01318-8

DO - 10.1016/S0006-8993(97)01318-8

M3 - Article

C2 - 9518610

AN - SCOPUS:0032473596

VL - 785

SP - 195

EP - 206

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -